Pharmacogenetics — Note on the better healing technique leading to development of New Pharmaceutical Business Model

Medicines have huge role in treating the patient in discomfort or in any ailment or disease. Here the role of drugs comes into play, as they work in order to boost the immune system and fighting mechanism of the body to deal and heal the body. The way drug or medicine works depends on many factors, such as, the composition of drug and percentage of composition of different components in the medicine.

Apart from this, recently it has been found out that, the genetic make up of the patients body, also makes the huge difference in the way, how drug acts on the body, and the outcome of drug on the body. Pharmacogenetics, has huge scope in coming years and future years, as it would help in developing systemic and constructive medicines which would not only benefit the patient personally but also can be utilized to develop a medicine suitable for particular demographic area of populace or population.

Pharmacogenetics, is the new phase of science, which would help the scientist and drug discoverers to develop, medicines which would have effective and efficient outcome in the way they treat the disease or ailments. Genetic make up of human is highly deep and complex, and now since, the genetic picture of human has been revealed recently, the new way of developing the targeted therapies would be easy to develop and market in the coming future.

Personalized medicines can be developed and boosted to treat the ailment once the genetic make up of the patient has been rolled out. It would help in developing constructive strategies not only in order to cure the disease, but also to develop counter medicines, in order to prevent future occurrence of ailments or disease.

Pharmacogenetics is the way of developing futuristic preventive drug dosage forms, as you already know, that, Prevention is better than cure. So, in our viewpoint, Pharmacogenetics is the way, we could achieve developing future medicines and future drug dosage forms, which would basically work on preventive basis, rather than presently, cure model.

Preventional model of medicines, would be thus, the future of medicine and pharmaceutical industry, which would help in powering the body of human, in restricting the attack from any microorganisms or pollutants which would compromise with the health of the respective person or human. Preventive medicines would help in making the body ready to deal with any sort of future attacks which may or could compromise the health or humans well being.

Pharmacogenetics, would be able to develop a shift in the drug development business model or the pharmaceutical business model. Hence, it would help in dealing with the current challenge of pharmaceutical industry, which is dealing with its business model, i.e., blockbuster molecule model, which has already taken a deep sink, in present years.

Pharmacogenetics, would help in building, a newer pharmaceutical business model, i.e., Preventive treatment molecular model. As this is, the future, and newer developments in this phase would be much better profitable and more effective as it would be, win – win – win model of business. Since, it would benefit, the manufacturers as well as the customers and consumers of the industry.

References

1.        Meloni R, Khalfallah O, Biguet NF. DNA microarrays and pharmacogenomics. Pharmacol Res. 2004;49:303–8.

2.       Ozdemir V, Williams-Jones B, Cooper DM, Someya T, Godard B. Mapping translational research in personalized therapeutics: From molecular markers to health policy. Pharmacogenomics. 2007;8:177–85.

3.       Ahn C. Pharmacogenomics in drug discovery and development. Genom Informat. 2007;5:41–5.

4.       Spear BB, Heath-Chioozi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med. 2001;5:201–4.